Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2244 - Assessing the Effectiveness of Proton Boron Fusion Therapy in Glioblastoma Cells
Speaker: Vasan, Arjun, MS - The University of Texas Health Science Center at Houston, Houston, TX
3:00 PM - 4:00 PM ET

2245 - Contrast-Enhanced Adaptive Stereotactic Body Radiotherapy (SBRT) for Multiple Hepatic Lesions with One Isocenter Using the Ethos Platform
Speaker: Vo, Kim, DO, MS - City of Hope Comprehensive Cancer Center, Duarte, CA
3:00 PM - 4:00 PM ET

2246 - Clinical Study of Hypofractionated Radiotherapy Combined with Temozolomide and Bevacizumab In the Treatment of Newly Diagnosed Postoperative Glioblastoma
Speaker: Wang, Can, MD, PhD - Chongqing university cancer hospital, Chongqing
3:00 PM - 4:00 PM ET

2247 - Comparative Study of Immunotherapy Combined with High-Dose vs. Standard-Dose Concurrent Chemoradiotherapy for Locally Advanced Cervical Esophageal Squamous Cell Carcinoma
Speaker: Wang, Can, MD, PhD - Chongqing university cancer hospital, Chongqing
3:00 PM - 4:00 PM ET

2248 - Comparative Effectiveness and Safety of Systemic Therapy Plus Interventional Therapy with or without Radiotherapy in CNLC Stage IIIA Hepatocellular Carcinoma: A Retrospective Study
Speaker: Wang, Jiaxin - Shandong Provincial Key Laboratory of Precision Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical-Sciences, Jinan, Shandong,, Jinan
3:00 PM - 4:00 PM ET

2249 - Consolidative Camrelizumab Following Definitive Concurrent Chemoradiotherapy In Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase 2 Trial
Speaker: Wang, Jun, MD, PhD, RT - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
3:00 PM - 4:00 PM ET

2250 - Exploring the Value of Additional Treatments Based on the Patterns of Failure After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
Speaker: Wang, Jun, MD, PhD, RT - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
3:00 PM - 4:00 PM ET

2251 - Dosimetric Comparison of Intensity-Modulated Radiotherapy, Helical Tomotherapy, and Intensity-Modulated Radiotherapy Based on Orthogonal Dual-Layer Multileaf Collimator In Cervical Esophageal Cancer Patients with Definitive Chemoradiotherapy
Speaker: Wang, Jun, MD, PhD, RT - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
3:00 PM - 4:00 PM ET

2252 - Nimotuzumab Combined with Chemoradiotherapy vs. Chemoradiotherapy Alone in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis of Survival and Safety Outcomes
Speaker: Wang, Lan, MD - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province
3:00 PM - 4:00 PM ET

2253 - Efficacy and Safety of Albumin-bound Docetaxel Plus Enlonstobart vs. Paclitaxel, Combined with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Unresectable Esophageal Squamous Carcinoma: Results from a Randomized Phase II Study
Speaker: Wang, Linlin, MD, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
3:00 PM - 4:00 PM ET

2254 - Impact of Neoadjuvant Chemotherapy vs. Chemoradiotherapy on Postoperative Complications and Surgical Outcomes in Locally Advanced Gastric Cancer: A Propensity Score-Matched Study
Speaker: Wang, Yifan - Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing
3:00 PM - 4:00 PM ET

2255 - Diffusion-Synthetic MRI Enables Privacy-Preserving Hybrid Training for Brain Tumor Auto-Segmentation In Radiotherapy
Speaker: Wang, Yu-Jen, MD, PhD - FJUH, New Taipei City, Taiwan